Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1
| Autor: | Circelli L1, Ramundo V, Marotta V, Sciammarella C, Marciello F, Del Prete M, Sabatino L, Izzo F, Scala S, Colao A, Faggiano A, Colantuoni V, Multidisciplinary Group for NeuroEndocrine Tumours of Naples, PASQUALI, Daniela |
|---|---|
| Přispěvatelé: | Circelli, Luisa, Ramundo, Valeria, Marotta, Vincenzo, Sciammarella, Concetta, Marciello, Francesca, DEL PRETE, Michela, Sabatino, Lina, Pasquali, Daniela, Izzo, Francesco, Scala, Stefania, Colao, Annamaria, Faggiano, Antongiulio, Colantuoni, Vittorio, Circelli, L1, Ramundo, V, Marotta, V, Sciammarella, C, Marciello, F, Del Prete, M, Sabatino, L, Izzo, F, Scala, S, Colao, A, Faggiano, A, Colantuoni, V, Multidisciplinary Group for NeuroEndocrine Tumours of, Naples |
| Rok vydání: | 2015 |
| Předmět: |
Male
Oncology Pathology medicine.disease_cause Germline polymorphism Gene Frequency 80 and over neuroendocrine tumour Child Multiple endocrine neoplasia Aged 80 and over Single Nucleotide Middle Aged Prognosis CDKN1B MEN1 neuroendocrine tumours polymorphisms prognosis Adolescent Adult Aged Base Sequence Case-Control Studies Child Preschool Cyclin-Dependent Kinase Inhibitor p27 Female Humans Molecular Sequence Data Multiple Endocrine Neoplasia Type 1 Phenotype Polymorphism Single Nucleotide Young Adult Genetic Predisposition to Disease Molecular Medicine Case-Control Studie Human medicine.medical_specialty Prognosi Single-nucleotide polymorphism Biology Internal medicine medicine Preschool Allele frequency Case-control study Original Articles Cell Biology medicine.disease Carcinogenesis |
| Zdroj: | Journal of Cellular and Molecular Medicine |
| ISSN: | 1582-1838 |
| DOI: | 10.1111/jcmm.12552 |
| Popis: | CDKN1B encodes the cyclin-dependent kinase inhibitor p27/Kip1. CDKN1B mutations and polymorphisms are involved in tumorigenesis; specifically, the V109G single nucleotide polymorphism has been linked to different tumours with controversial results. Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant syndrome, characterized by the development of different types of neuroendocrine tumours and increased incidence of other malignancies. A clear genotype–phenotype correlation in MEN1 has not been established yet. In this study, we assessed whether the CDKN1B V109G polymorphism was associated with the development of aggressive tumours in 55 consecutive patients affected by MEN1. The polymorphism was investigated by PCR amplification of germline DNA followed by direct sequencing. Baseline and follow-up data of tumour types and their severity were collected and associated with the genetic data. MEN1-related aggressive and other malignant tumours of any origin were detected in 16.1% of wild-type and 33.3% of polymorphism allele-bearing patients (P = NS). The time interval between birth and the first aggressive tumour was significantly shorter in patients with the CDKN1B V109G polymorphism (median 46 years) than in those without (median not reached; P = 0.03). Similarly, shorter was the time interval between MEN1 diagnosis and age of the first aggressive tumour (P = 0.02). Overall survival could not be estimated as 96% patients were still alive at the time of the study. In conclusion, CDKN1B V109G polymorphism seems to play a role in the development of aggressive tumours in MEN1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text